DANIEL SON: Open Payments
NPI 1801658604 · MILFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,659 in 105 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $2,659
Food & beverage: $2,659
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $848 |
| Regeneron Healthcare Solutions, Inc. | 9 | $314 |
| GENZYME CORPORATION | 9 | $245 |
| LEO Pharma Inc. | 11 | $238 |
| UCB, Inc. | 4 | $204 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 8 | $180 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $96 |
| Janssen Biotech, Inc. | 4 | $95 |
| Novartis Pharmaceuticals Corporation | 4 | $86 |
| Amgen Inc. | 4 | $81 |
Products named: DUPIXENT, SKYRIZI, RINVOQ, Bimzelx, Cabtreo, ADBRY, Winlevi, TREMFYA.
Industry payments across CT — which companies pay providers there.
